The construction of a pharmaceutical cluster has begun in the Esipovo Industrial Park

496
2
Government of the Moscow Region 17 November 2026 08:49

Avexima has begun construction of a pharmaceutical cluster with an area of more than 170,000 square meters on the territory of the Esipovo Industrial Park in the Moscow region. The launch of the first stage of the project is scheduled for 2027, it will be implemented within eight years, the press service of the Ministry of Investment, Industry and Science of the Moscow region reports.

"Avexima has started construction of a complex on the territory of the Esipovo Industrial Park, where it plans to carry out the entire production cycle of medicines. Thus, the investment project includes the creation of a laboratory where the company will develop new drugs. Investments in the project amount to about 6.5 billion rubles. In total, the company will create more than 1.5 thousand jobs for residents of the region," said Ekaterina Zinovieva, Deputy Chairman of the regional government and Minister of Investment, Industry and Science of the Moscow Region.

The company's production complex in The Moscow region will be built in accordance with the requirements of international quality standards.

"To create medicines, our company conducts its own scientific research and development. In the Moscow region, the company will develop and manufacture drugs for the treatment of diseases in the fields of cardiology, endocrinology, gastroenterology, gynecology, dermatology, neurology, immunology and oncology. The establishment of the plant in the Esipovo Industrial Park will allow the company to combine scientific activities, as well as production and logistics processes on one site," said Ivan Halepo, General Director of Avexima.

The management company of the Esipovo Industrial Park is the Moscow Region Development Corporation.

"The Esipovo Industrial Park has created all the necessary infrastructure for the implementation of projects in various industries, including pharmaceuticals. Today, Avexim's portfolio already includes about 120 medicines, and the implementation of the project, which includes its own laboratory, will significantly increase this figure," said Egor Kruglov, Acting General Director of the Moscow Region Development Corporation.

Please note that this press release is based on materials provided by the company. AK&M Information Agency shall not be held liable for its contents, nor for the legal and other consequences of its publication.